Clinical Trial Update: A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated Rituximab for anticoagulation-resistant manifestations of antiphospholipid syndrome; results from the completed study were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Antiphospholipid Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-10-31